BNTC - Company ID 0001808898
The table below shows Benitec Biopharma Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$23.59M | -$19.40M | -$18.01M | -$15.90M | -$12.83M | -$7.54M |
| Capital expenditure | $18.00K | $179.00K | $1.00K | $13.00K | $221.00K | $95.00K |
| Investing cash flow | -$18.00K | -$179.00K | -$1.00K | -$13.00K | -$221.00K | -$94.00K |
| Dividends paid | - | - | - |
Benitec Biopharma Inc. reported operating cash flow of -$23.59M for fiscal year 2025. That is down 21.6% from -$19.40M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from $4.79M (FY 2019) to -$23.59M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $70.48M | $68.03M | $16.02M | - | $22.52M | $1.77M |